No increase in new users of blood glucose-lowering drugs in Norway 2006-2011: A nationwide prescription database study

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Strøm, Hanne ^a   Selmer, Randi ^a   Birkeland, Kåre I ^b,e   Schirmer, Henrik ^c,d   Berg, Tore Julsrud ^b,e   Jenum, Anne Karen ^e,f   Midthjell, Kristian ^g   Berg, Christian ^a   Stene, Lars Christian ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f OSLO METROPOLITAN UNIVERSITY   (Norway)

^g NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Blood glucose lowering drugs; Diabetes; Incidence; Norway; Prescription database; Prevalence

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; DIABETES MELLITUS; FACTUAL DATABASE; FEMALE; HUMAN; HYPERGLYCEMIA; INFANT; MALE; MIDDLE AGED; NORWAY; PRESCHOOL CHILD; PRESCRIPTION; SEX RATIO; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DIABETES MELLITUS; DRUG PRESCRIPTIONS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; MALE; MIDDLE AGED; NORWAY; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84901975848     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-520     Document Type: Article

References (22)

1. Global estimates of the prevalence of diabetes for 2010 and 2030. Shaw JE, Sicree RA, Zimmet PZ, Diabetes Res Clin Pract 2010 87 4 14 10.1016/j.diabres.2009.10.007 19896746
2. Reporting participation in epidemiologic studies: a survey of practice. Morton LM, Cahill J, Hartge P, Am J Epidemiol 2006 163 197 203 16339049 (Pubitemid 43145745)
3. The influence of non-response in a population-based cohort study on type 2 diabetes evaluated by the Swedish prescribed drug register. Eriksson AK, Ekbom A, Hilding A, Östenson CG, Eur J Epidemiol 2012 27 153 162 10.1007/s10654-011-9630-1 22089424
4. Register-based studies of diabetes. Carstensen B, Borch-Johnsen K, Scand J Public Health 2011 39 175 179 10.1177/1403494811404279 21775379
5. Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality? Evans JM, Barnett KN, Ogston SA, Morris AD, Diabetologia 2007 50 729 732 10.1007/s00125-006-0585-9 17225122 (Pubitemid 46355822)
6. Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Skrivarhaug T, Stene LC, Drivvoll AK, Strøm H, Joner G, Norwegian Childhood Diabetes Registry, Diabetologia 2014 57 57 62 10.1007/s00125-013-3090-y 24149838
7. Counting drugs to understand the disease: the case of measuring the diabetes epidemic. Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W, Popul Health Metr 2007 5 2 10.1186/1478-7954-5-2 17313683 (Pubitemid 46359492)
8. Establishment of the nationwide Norwegian Prescription Database (NorPD)-new opportunities for research in pharmacoepidemiology in Norway. Furu K, Norwegian J Epidemiol 2008 18 129 136 (available from: http://www.ntnu.no/ ojs/index.php/norepid/article/view/23/17) (Pubitemid 351859935)
9. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC Classification and DDD assignment, Oslo, 2012. WHO Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health 2013 (available from: http://www.whocc.no/filearchive/publications/1-2013guidelines.pdf)
10. WHO Collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs, Oslo, 2012. WHO Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health 2013 (available from: http://www.whocc.no/atc-ddd-publications/atc-ddd-index/)
11. Epidemiology of type 2 diabetes. Ma RC, Tong PC, Textbook of Diabetes, Volume 4 4 Wiley-Blackwell, Oxford, Holt RI, Cockram CS, Flyvbjerg A, Goldstein BJ, 2010 45 68
12. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R, BMJ 2008 337 236 10.1136/bmj.39582.447998.BE 18595902 (Pubitemid 352017231)
13. Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo. Tran AT, Diep LM, Cooper JG, Claudi T, Straand J, Birkeland K, Ingskog W, Jenum AK, Norway BMC Health Serv Res 2010 10 145 10.1186/1472-6963-10-145
14. Quality of care for patients with type 2 diabetes in primary care in Norway is improving: results of cross-sectional surveys of 33 general practices in 1995 and 2005. Cooper JG, Claudi T, Jenum AK, Thue G, Hausken MF, Ingskog W, Sandberg S, Diabetes Care 2009 32 81 83 10.2337/dc08-0605 18852338
15. The gap between guidelines and practice in the treatment of type 2 diabetes A nationwide survey in Norway. Jenssen TG, Tonstad S, Claudi T, Midthjell K, Cooper J, Diabetes Res Clin Pract 2008 80 314 320 10.1016/j.diabres.2007.12.025 18279994
16. Gudbjornsdottir S, Eliasson B, Cederholm J, Zethelius B, Svensson AM, Samuelsson P, Annual Report of the Swedish Diabetes Register, 2011 [In Swedish] The Swedish Diabetes Register 2012 available from: https://www.ndr.nu/pdf/NDR- rapport2011-LR.pdf
17. Unlicensed use of metformin in children and adolescents in the UK. Hsia Y, Dawoud D, Sutcliffe AG, Viner RM, Kinra S, Wong IC, Br J Clin Pharmacol 2012 73 135 139 10.1111/j.1365-2125.2011.04063.x 21762204
18. Polycystic ovary syndrome in adolescents: current and future treatment options. Mastorakos G, Lambrinoudaki I, Creatsas G, Paediatr Drugs 2006 8 311 318 10.2165/00148581-200608050-00004 17037948 (Pubitemid 44607536)
19. Use of metformin in pediatric age. Brufani C, Fintini D, Nobili V, Patera PI, Cappa M, Brufani M, Pediatr Diabetes 2011 12 580 588 21366813
20. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF, J Clin Endocrinol Metab 2000 85 2434 2438 10902790 (Pubitemid 32269197)
21. The incidence of type 1 (insulin-dependent) diabetes mellitus 15-29 years in Norway 1978-1982. Joner G, Søvik O, Diabetologia 1991 34 271 274 10.1007/BF00405087 2065861
22. High levels of education are associated with an increased risk of latent autoimmune diabetes in adults: results from the Nord-Trondelag health study. Olsson L, Ahlbom A, Grill V, Midthjell K, Carlsson S, Diabetes Care 2011 34 102 107 10.2337/dc10-1061 20937690